Parliamentary Committee Refers Draft Back to Subcommittee
Parliamentary Initiative 20.473, submitted by Heinz Siegenthaler, has aimed to establish a legal framework for controlled cannabis distribution to adults for over five years. After the public consultation period, the revised draft was ready for further review by the SGK-N (Commission for Social Security and Health of the National Council). In early May, the commission decided not to proceed to a plenary debate but instead tasked a subcommittee with revisions. The justification: the public consultation generated numerous amendment requests that needed to be incorporated before achieving majority support.
📑 Inhaltsverzeichnis
In parliamentary procedure, referral to a subcommittee is standard practice when a proposal requires deeper technical scrutiny in a smaller working group. Politically, however, it routinely means additional months without a final decision. For ongoing pilot projects in Basel, Bern, Biel, Lausanne, Lucerne, Vernier, and Zurich, this means continued operation under existing special permits while a comprehensive federal-level solution remains outstanding.
IG Hanf Schweiz Demands Binding Transitional Solutions
The industry association IG Hanf Schweiz has reacted critically to the referral, voicing concerns about the political pace. In a statement, the organization demands binding transitional solutions for ongoing pilot projects, a clear timeline for further proceedings, and practical legal alternatives to combat the black market. The IG argues that every additional delay complicates investment planning and undermines stakeholder confidence in the regulatory process.
Behind these demands lies the observation that pilot projects have generated data crucial to regulatory discussions. Swiss pilots have demonstrated that controlled distribution can push back the black market without increasing overall consumption. We reported in April on how the Swiss cannabis pilot visibly displaces the black market. Without a legal framework, these findings risk being politically sidelined.
Switzerland’s Unique Approach Under Time Pressure
The political context has shifted significantly since the initiative was submitted in 2020. Germany legalized home cultivation and growing associations through its 2024 Cannabis Act, the Czech Republic is working on a regulated market, and several EU states are piloting regulatory models. Switzerland, long a pioneer with its scientifically supervised pilot projects, now risks falling behind in regulatory momentum. While Zurich extended its Züri Can pilot through 2028, the federal level still lacks a roadmap for transitioning to an orderly legal market.
Content-wise, the SGK-N debate centers on several unresolved issues. Points of contention include advertising and promotion regulations, cantonal involvement in licensing, youth protection, and connections to addiction support and prevention. Each topic generated proposals from the consultation period pointing in sometimes contradictory directions. The subcommittee must forge these into a consensus-capable draft.
What Happens Until the Next Review?
Until a new draft returns to the SGK-N, the status quo continues. Pilot projects operate under current special permits, sales in Swiss pharmacies remain limited to medicinal cannabis, and the CBD market operates in the gray zone regularly criticized by Swiss researchers. For the German cannabis industry, Swiss delays represent more than a footnote. Swiss actors provide study results, regulatory blueprints, and in some cases production experience that flow into DACH-wide discussions.
When the subcommittee completes its work remains unclear. Realistically, a new review before the SGK-N could occur in autumn 2026, possibly not until early 2027. Subsequently, both chambers of parliament would need to approve the draft before an ordinance establishes the operational framework. Years may pass before a regulated legal market for adults actually exists. Until then, pilot projects and the black market will continue operating in parallel.
Frequently Asked Questions
What is the Siegenthaler Parliamentary Initiative 20.473?
Submitted in 2020 by former National Councilor Heinz Siegenthaler, this initiative aims to establish the legal foundation for controlled cannabis distribution to adults in Switzerland. It forms the basis for the current legislative draft under review by the SGK-N.
What does referral to a subcommittee mean?
The proposal undergoes more detailed revision in a smaller SGK-N working group before returning to the full commission and eventually parliament. Substantively, the referral means central points of contention from the consultation period must be reassessed.
What impact does the delay have on ongoing pilot projects?
Pilot projects in Basel, Bern, Biel, Lausanne, Lucerne, Vernier, and Zurich continue operating under time-limited special permits. Binding transitional rules into a federally regulated system remain absent. IG Hanf Schweiz therefore explicitly demands transitional solutions.
How does Switzerland compare to Germany?
Since 2024, Germany has permitted home cultivation and growing associations while establishing its own medicinal cannabis law. Switzerland continues relying on time-limited pilot projects and a legally restrictive CBD market. In transitioning to an orderly legal market for adults, Switzerland lags behind Germany.
When can a decision be expected?
A realistic timeframe for the SGK-N’s next review is autumn 2026 or early 2027. This would be followed by deliberations in both chambers of parliament and an implementing ordinance. Additional years should be anticipated before a regulated market actually launches.
Sources: Hanfjournal, May 9, 2026; IG Hanf Schweiz statement; SGK-N commission announcement regarding Pa.Iv. 20.473.










































